1.12
price down icon7.44%   -0.09
after-market Dopo l'orario di chiusura: 1.10 -0.02 -1.79%
loading

Rani Therapeutics Holdings Inc Azioni (RANI) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
4.47%
14.03
13.43 17.86 18.29 16.52
Interest Income/Expense
0.15%
1.294
1.296 1.316 1.266 1.207
Depreciation and Amortization
9.25%
0.248
0.227 0.218 0.189 0.188
Operating Income/Loss
4.47%
-14.03
-13.43 -17.86 -18.29 -16.52
Income/Loss From Continuing Operations Before Tax
5.15%
-14.78
-14.05 -18.33 -18.66 -16.83
Income/Loss From Continuing Operations After Tax
5.15%
-14.78
-14.05 -18.33 -18.66 -16.83
Net Income/Loss
5.15%
-14.78
-14.05 -18.33 -18.66 -16.83
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
4.87%
-7.296
-6.957 -9.135 -9.361 -8.46
Basic Average Shares
202.68%
26.03
-25.35 25.55 25.34 25.24
Diluted Average Shares
202.68%
26.03
-25.35 25.55 25.34 25.24
Basic Earnings Per Share
87.87%
-0.29
-2.39 0.36 0.37 0.33
Diluted Earnings Per Share
87.87%
-0.29
-2.39 0.36 0.37 0.33
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$60.29
price down icon 0.48%
$68.09
price down icon 1.58%
$17.32
price down icon 0.23%
$31.03
price down icon 0.26%
$86.82
price down icon 1.40%
biotechnology ONC
$220.54
price down icon 7.53%
Capitalizzazione:     |  Volume (24 ore):